United States · FDA National Drug Code directory
Spritam
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 43485-102_890ef534-7363-4f2b-b125-8f62e2eb26d0
- Product NDC
- 43485-102
- Form
- TABLET, FOR SUSPENSION
- Composition / generic term
- levetiracetam
- Labeler
- Aprecia Pharmaceuticals, LLC
- Marketing category
- NDA
- Marketing start / end (source format)
- 20160205
- Source listing expiry
- 20261231
Source-listed ingredients
- LEVETIRACETAM — 500 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 6 BLISTER PACK in 1 CARTON (43485-102-03) / 1 TABLET, FOR SUSPENSION in 1 BLISTER PACK (43485-102-01) · 43485-102-03
- 60 BLISTER PACK in 1 CARTON (43485-102-60) / 1 TABLET, FOR SUSPENSION in 1 BLISTER PACK (43485-102-01) · 43485-102-60
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →